Freenome (FRNM) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Based on 5 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Guggenheim | Initiated Coverage | Buy | $21.00 | Aug 20, 2026 |
| TD Cowen | Initiated Coverage | Buy | $17.00 | Aug 18, 2026 |
| BTIG | Initiated Coverage | Buy | $17.00 | Aug 17, 2026 |
| Jefferies | Initiated Coverage | Buy | $17.00 | Aug 17, 2026 |
| Leerink Partners | Initiated Coverage | Outperform | $18.00 | Aug 14, 2026 |
Frequently asked questions
What is the price target for FRNM stock?
The average 12-month analyst price target for Freenome (FRNM) is $18.00, with a high estimate of $21.00 and a low of $17.00, across 5 analysts.
Is FRNM a buy, sell, or hold?
Analysts covering Freenome currently average a Buy rating: 5 buy, 0 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for FRNM?
The average price target of $18.00 implies 22.12% upside from the last price of $14.74.
What is the latest analyst rating on FRNM?
On Aug 20, 2026, Guggenheim initiated coverage of Freenome at Buy with a price target of $21.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.